Earnings season continues with another busy, market-moving week ahead, as companies across autos, consumer staples, technology, healthcare, energy, utilities, financials, REITs, and materials step into the spotlight.
The upcoming results span legacy bellwethers and high-growth disruptors alike, ranging from Ford (F) in autos and consumer giants such as Coca-Cola (KO), McDonald’s (MCD), Kraft Heinz (KHC), and British American Tobacco (BTI), to technology and platform names including Cisco (CSCO), Shopify (SHOP), Applied Materials (AMAT), Cloudflare (NET), Datadog (DDOG), Spotify (SPOT), AppLovin (APP), and Arista Networks (ANET).
Healthcare and pharmaceuticals will be closely watched with updates from Gilead Sciences (GILD), Moderna (MRNA), Vertex Pharmaceuticals (VRTX), AstraZeneca (AZN), Organon (OGN), and CVS Health (CVS), keeping drug pipelines, pricing, utilization trends, and margins in focus.
Energy, utilities, and materials names such as BP (BP), Enbridge (ENB), Duke Energy (DUK), Albemarle (ALB), Vale (VALE), Cameco (CCJ), Agnico Eagle Mines (AEM), Cleveland-Cliffs (CLF), and DuPont (DD) will provide insight into commodity-linked earnings, capital discipline, and demand trends.
High-volatility and growth-oriented sectors will also be active, with results from Coinbase (COIN), Robinhood (HOOD), DraftKings (DKNG), Upstart (UPST), Rivian (RIVN), QuantumScape (QS), Unity Software (U), Roku (ROKU), Fastly (FSLY), Airbnb (ABNB), Pinterest (PINS), and Nebius Group (NBIS), keeping sentiment, guidance, and balance-sheet strength firmly in focus.
Rounding out the week are updates from REITs, telecom, and infrastructure-focused businesses, including W. P. Carey (WPC), STAG Industrial (STAG), Iron Mountain (IRM), T-Mobile US (TMUS), and ON Semiconductor (ON), offering signals on leasing activity, data infrastructure demand, and connectivity trends.
Altogether, the lineup offers a broad read-through on demand, margins, capital spending, and risk appetite as markets digest the next phase of earnings season.
Below is a rundown of major quarterly updates anticipated in the week of February 9 to February 13:
Monday, February 9
Cleveland-Cliffs (CLF)
Cleveland-Cliffs (CLF) is set to report Q4 earnings before the market opens on Monday, with Wall Street forecasting a high-single-digit Y/Y increase in both EPS and revenue.
Sentiment around the steelmaker remains mixed:
Morgan Stanley recently upgraded CLF to Overweight, lifting its price target to $17 from $12.80, arguing that, despite soft demand, elevated steel prices, and a challenging cost environment, Cleveland-Cliffs stands out as the only U.S. steel producer capable of meaningful balance-sheet and structural transformation. Analyst Carlos De Alba highlighted a potential strategic partnership with Posco (PKX) as a key catalyst that could address CLF’s high leverage and elevated interest burden, which is expected to exceed $600M this year. Without such action, Morgan Stanley estimates CLF could post a ~$1.3B net loss in 2025, even with supportive steel pricing.
In contrast, KeyBanc Capital Markets downgraded CLF to Sector Weight from Overweight, citing valuation concerns and modestly higher cost assumptions, after the stock surpassed its prior $13 price target and analysts trimmed estimates for 4Q25–2026.
Seeking Alpha’s Quant Rating remains at Hold, in line with the broader Wall Street consensus.
However, SA contributor Oakoff Investments maintains a Buy, citing ~37% upside over a 12–24-month horizon. The bullish thesis hinges on a favorable mix shift toward auto-grade and coated steel, improved pricing spreads, long-term OEM contracts extending into 2027–28, and management’s footprint optimization, lower capex, and extended debt maturities.
- Consensus EPS Estimates: -$0.62
- Consensus Revenue Estimates: $4.59B
- Earnings Insight: The company has beaten revenue expectations in just 2 of the past 8 quarters, and EPS in 50% of those reports.
Also reporting: ON Semiconductor (ON), Opendoor Technologies (OPEN), Becton, Dickinson & Co. (BDX), Danaos (DAC), Upwork (UPWK), Chegg (CHGG), Goodyear Tire & Rubber Company (GT), Apollo Global Management (APO), Anavex Life Sciences (AVXL), Dynatrace (DT), and more.
Tuesday, February 10
Ford Motor (F)
Ford (F) is scheduled to report Q4 earnings after the close on Tuesday, with consensus expectations calling for a ~51% Y/Y decline in EPS on a ~7% drop in revenue.
Operationally, Ford continues to execute well in the U.S. market. 2025 vehicle sales rose 6% to 2.2M units, lifting market share to 13.2%, with Q4 sales up 2.7%, again outperforming the industry, with market share increasing in Q4 by 0.9 percentage points. It was Ford’s best annual sales and Q4 performance since 2019, placing the company in third place behind Toyota Motor (TM) and General Motors (GM). The F-Series marked its 44th consecutive year as America’s best-selling truck, with volumes up 8.3% Y/Y, while hybrid sales surged 21.7%. The Ford Maverick posted record demand, and Ford Pro remains a bright spot, with Pro Intelligence subscriptions up 30% Y/Y to ~840K active users. These trends underscore Ford’s strength in core trucks, commercial vehicles, and affordable hybrid offerings.
Despite strong unit momentum, profitability remains under pressure. Analysts expect a sharp earnings decline, and 2025 adjusted free cash flow guidance was cut to $2B–$3B, reflecting margin pressure, elevated costs, and cyclical headwinds.
Both Wall Street and Seeking Alpha Quant rate the stock a Hold, citing limited near-term growth visibility.
SA contributor Joseph Parrish views Ford as a classic cyclical, arguing upside is capped at current levels and that more attractive risk/reward emerges only below $10.50, given pressured margins and constrained earnings leverage.
- Consensus EPS Estimates: $0.19
- Consensus Revenue Estimates: $41.78B
- Earnings Insight: Ford has missed EPS in one and revenue expectations in 2 of the past 8 quarters.
Also reporting: Coca-Cola Company (KO), Gilead Sciences (GILD), BP p.l.c (BP), CVS Health (CVS), W. P. Carey (WPC), Cloudflare (NET), Duke Energy (DUK), DuPont (DD), Upstart Holdings (UPST), AstraZeneca (AZN), Datadog (DDOG), Spotify Technology (SPOT), Zillow (Z), American International Group (AIG), Williams Companies (WMB), Jumia Technologies AG (JMIA), Marriott International (MAR), OrganiGram (OGI), Welltower (WELL), Lyft (LYFT), Fiserv (FISV), Exelixis (EXEL), S&P Global (SPGI), Robinhood Markets (HOOD), and more.
Wednesday, February 11
Cisco Systems (CSCO)
Cisco Systems (CSCO) reports FQ2 results after Wednesday’s close, with consensus calling for 8%+ Y/Y growth in both revenue and earnings, reflecting improving demand across core networking and early traction in AI-related infrastructure.
Wall Street analysts maintain a Buy rating on the tech giant, while Seeking Alpha’s Quant Rating system suggests a Hold.
Last month, Evercore upgraded the stock to Outperform from In Line, hiking the price target to $100 from $80, arguing CSCO blends cyclical and secular strengths for high-single-digit sales and low-teens EPS growth at under 20x P/E versus peers. Tailwinds include a campus refresh cycle (6-8% industry growth through 2026 via WiFi 7, PoE, and legacy EOL/EOS), surging AI momentum ($3B FY26 revenue, >$4B orders from hyperscalers on Silicon One/P200 ramps, and 25%+ optics growth), telco/enterprise recovery for diversification, and 50-100bps annual EBIT expansion.
Seeking Alpha contributor Rafa F. Oliver rates Cisco (CSCO) a Buy with an $85.9 price target, implying 14.2% upside. The investment case rests on 6–7% annual growth, supported by rising AI infrastructure demand, a multi-year campus networking upgrade cycle, and network security expansion following the Splunk acquisition. While margin pressure persists as Cisco adapts to AI-driven competition, reflected in EBITDA margins near 30% and operating margins around 20%, the risks remain manageable.
- Consensus EPS Estimates: $1.02
- Consensus Revenue Estimates: $15.11B
- Earnings Insight: Cisco has beaten EPS and revenue estimates in 8 straight quarters.
Also reporting: Shopify (SHOP), McDonald’s (MCD), Kraft Heinz Company (KHC), Unity (U), QuantumScape (QS), Fastly (FSLY), STAG Industrial (STAG), Albemarle (ALB), T-Mobile US (TMUS), NNN REIT (NNN), Chimera Investment (CIM), Antero Midstream (AM), Equinix (EQIX), Manulife Financial (MFC), HubSpot (HUBS), Antero Resources (AR), and more.
Thursday, February 12
Airbnb (ABNB)
Airbnb (ABNB) is scheduled to report Q4 earnings after the close on Thursday, with analysts forecasting a 9% Y/Y decline in EPS despite a 9% increase in revenue.
Wall Street maintains a Buy rating on the stock, while Seeking Alpha’s Quant Rating remains at Hold, reflecting ongoing valuation concerns.
Seeking Alpha contributor IWA Research also rates ABNB a Hold, noting that shares trade close to intrinsic value, leaving a limited margin of safety. While Airbnb benefits from a strong balance sheet, disciplined buybacks, and manageable debt, near-term growth faces pressure from regulatory headwinds in key markets.
On the upside, the author highlights longer-term drivers, including hotel integration, international expansion, and AI-led product initiatives. On the downside, tightening regulations continue to weigh on the outlook, ranging from a proposed short-term rental ban in Barcelona by 2028 to strict caps across cities such as London and Paris, which could constrain supply and growth over time.
- Consensus EPS Estimates: $0.66
- Consensus Revenue Estimates: $2.71B
- Earnings Insight: Airbnb has surpassed revenue expectations for 8 consecutive quarters and beaten EPS estimates in 4 of those reports.
Also reporting: Roku (ROKU), Organon (OGN), Twilio (TWLO), Applied Materials (AMAT), Iron Mountain (IRM), Coinbase Global (COIN), Pinterest (PINS), DraftKings (DKNG),Vertex Pharmaceuticals (VRTX), Agnico-Eagle Mines (AEM), Rivian Automotive (RIVN), Wynn Resorts (WYNN), Arista Networks (ANET), Howmet Aerospace (HWM), Federal Realty Investment Trust (FRT), Himax Technologies (HIMX), Anheuser-Busch InBev (BUD), American Electric Power Company (AEP), Exelon (EXC), GEO Group (GEO), Expedia (EXPE), and more.
Friday, February 13
Moderna (MRNA)
Moderna (MRNA) is set to report its Q4 results before Friday’s market open, with analysts expecting a steep ~65% Y/Y decline in revenue as pandemic-era demand continues to normalize. The stock has nevertheless gained ~22% over the past 12 months and is up ~39% YTD in 2026.
Both Wall Street analysts and Seeking Alpha’s Quant Rating system maintain a Hold rating, reflecting a balanced risk-reward profile.
Seeking Alpha contributor Biotech Beast also rates the stock as a hold, citing encouraging long-term data from Moderna’s cancer vaccine program. Updated five-year Phase 2b results for intismeran autogene showed a 49% reduction in death or recurrence in melanoma, with potential Phase 3 melanoma and Phase 2 renal cell carcinoma readouts possible in 2026.
From a financial standpoint, Moderna’s preliminary 2025 outlook points to approximately $1.9B in revenue against $5.0B–$5.2B in GAAP operating expenses, underscoring ongoing profitability and cash burn challenges.
Meanwhile, Seeking Alpha Investing Group Leader Edmund Ingham notes that Moderna, alongside Novavax, is transitioning from pandemic-driven revenue toward cost discipline and pipeline execution, with breakeven targeted around 2028. Moderna’s longer-term upside remains tied to successful commercialization of its COVID/flu combination vaccine, RSV program, and oncology pipeline, albeit with higher execution risk given elevated spending and the absence of large strategic partners.
- Consensus EPS Estimates: -$2.65
- Consensus Revenue Estimates: $623.93M
- Earnings Insight: Moderna has beaten EPS and revenue estimates in 7 of the past 8 quarters.
Also reporting: Cameco (CCJ), TC Energy (TRP), Magna International (MGA), Wendy’s International (WEN), Advance Auto Parts (AAP), and more.